GNH USA

Europe — EMA

Paliperidon Teva (Paliperidone Palmitate)

GNH USA supplies Paliperidon Teva (Paliperidone palmitate), an antipsychotic for schizophrenia and schizoaffective disorder. Request a quote for supply.

Request sourcing

1
Pack/s

What is Paliperidone Palmitate?

Paliperidone palmitate, the active ingredient in Paliperidon Teva, is an atypical antipsychotic presented as an intramuscular injection for intramuscular use. It is indicated for the treatment of schizophrenia and schizoaffective disorder in adult patients, providing long‑acting symptom control.

GNH USA supplies Paliperidon Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide, ensuring reliable quality and regulatory compliance across markets. Our distribution network adheres to stringent cold‑chain standards where required, and we provide comprehensive documentation to facilitate import and registration processes.

What is Paliperidone Palmitate used for?

Paliperidone palmitate is an atypical antipsychotic used in the management of chronic psychotic disorders. - Schizophrenia: reduces relapse risk and maintains symptom control in adult patients. - Schizoaffective disorder: helps stabilize mood and psychotic symptoms as part of maintenance therapy. - Maintenance treatment of schizophrenia: provides long‑acting injectable therapy to improve adherence.

What are the side effects of Paliperidone Palmitate?

Paliperidone palmitate may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Injection site pain: discomfort at the injection site. - Weight gain: increase in body weight. - Akathisia: restlessness or urge to move. - Sedation: drowsiness or reduced alertness.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: life‑threatening reaction with fever and rigidity. - Tardive dyskinesia: persistent involuntary movements. - Orthostatic hypotension: significant drop in blood pressure on standing. - Severe allergic reactions: anaphylaxis or angioedema.

What precautions apply to Paliperidone Palmitate?

When prescribing paliperidone palmitate, clinicians should consider several precautionary measures to ensure safe use. - Assess cardiovascular status: monitor for orthostatic hypotension and arrhythmias. - Evaluate metabolic profile: watch for weight gain, glucose, and lipid changes. - Screen for movement disorders: monitor for extrapyramidal symptoms and tardive dyskinesia. - Review concomitant medications: avoid drugs that prolong QT interval. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

What does Paliperidone Palmitate interact with?

Paliperidone palmitate can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inducers: may reduce plasma levels and effectiveness. - QT‑prolonging agents: increase risk of cardiac arrhythmias. - Antihypertensive drugs: additive effect on blood pressure lowering.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors: may raise paliperidone concentrations. - CNS depressants: enhance sedation or dizziness. - Anticholinergic agents: may worsen cognitive side effects.

Frequently asked questions

What is Paliperidon Teva used for?+
Paliperidon Teva contains paliperidone palmitate, a long‑acting injectable antipsychotic indicated for the treatment of schizophrenia and schizoaffective disorder in adult patients. It is used as a maintenance therapy to reduce relapse risk and improve adherence by providing sustained drug exposure over several weeks after each intramuscular injection.
How does paliperidone palmitate work?+
Paliperidone palmitate works by blocking dopamine D2 receptors and serotonin 5‑HT2A receptors in the brain, which diminishes dopaminergic and serotonergic neurotransmission associated with psychotic symptoms. Additional antagonism of α1‑adrenergic and histamine H1 receptors contributes to its overall effect, while the depot formulation maintains steady plasma levels for weeks, supporting continuous symptom control.
What is the usual dose of Paliperidon Teva?+
The dosing regimen for paliperidone palmitate is individualized by the prescribing clinician based on the patient’s clinical status, prior response, and tolerability. The prescriber determines the injection strength, interval (typically every 4 weeks after the initial loading doses), and any necessary adjustments, following the product’s approved labeling and local guidelines.
Is Paliperidon Teva safe during pregnancy or breastfeeding?+
Safety data for paliperidone palmitate in pregnancy and lactation are limited, and the drug is generally prescribed only when the potential benefits to the mother outweigh any possible risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and alternative treatment options with their healthcare provider.
How do I order Paliperidon Teva from GNH USA?+
To request Paliperidon Teva, visit the product page on gnh-usa.com, enter the required quantity, and submit the enquiry form. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed), and assistance with import documentation.
How does Paliperidon Teva compare with other antipsychotics?+
Compared with oral atypical antipsychotics, paliperidone palmitate offers a long‑acting injectable option that improves adherence by reducing the need for daily dosing. Relative to other depot antipsychotics, it shares a similar receptor profile but differs in dosing intervals and formulation. Clinicians consider efficacy, side‑effect profile, patient preference, and previous treatment response when selecting between paliperidone palmitate and alternative agents.
What are the storage requirements for Paliperidon Teva?+
Paliperidon Teva should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. The product must not be frozen or exposed to extreme temperatures. Proper storage helps maintain the stability of the injectable suspension and ensures the medication remains effective until the expiration date.
How is Paliperidon Teva administered?+
Paliperidon Teva is given as an intramuscular injection, typically into the deltoid or gluteal muscle, by a qualified healthcare professional. The initial regimen usually involves one or two loading doses to rapidly achieve therapeutic plasma concentrations, followed by maintenance injections at regular intervals (often every four weeks). Injection technique and site rotation are important to minimize local reactions.
What are the most serious risks associated with Paliperidon Teva?+
The most serious adverse reactions to consider include neuroleptic malignant syndrome, a potentially fatal condition characterized by fever, muscle rigidity, and autonomic instability; tardive dyskinesia, which may cause persistent involuntary movements; and severe allergic reactions such as anaphylaxis. Patients should be monitored closely for early signs of these events, and treatment should be discontinued if they occur.
Who should not use Paliperidon Teva?+
Paliperidon Teva is contraindicated in individuals with known hypersensitivity to paliperidone, paliperidone palmitate, or any excipients in the formulation. It should also be avoided in patients with a history of neuroleptic malignant syndrome or severe uncontrolled cardiovascular conditions. Caution is advised for those with significant hepatic or renal impairment, and the medication should be used only under close medical supervision in such cases.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Paliperidone Palmitate
Route
Intramuscular Use
Manufacturer
Teva Gmbh
Origin
EU

Related products